A major advance in cancer research is arising with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer inhibitor protein is frequently lost in various forms of tumors, leading uncontrolled https://followbookmarks.com/story22069857/vhh-fragments-revive-tumor-suppressor-p53-a-new-approach-for-tumor-therapy